DK0998276T3 - Use of alkanoylcarnitine derivatives to treat attention deficit / hyperactive disorders - Google Patents

Use of alkanoylcarnitine derivatives to treat attention deficit / hyperactive disorders

Info

Publication number
DK0998276T3
DK0998276T3 DK98932502T DK98932502T DK0998276T3 DK 0998276 T3 DK0998276 T3 DK 0998276T3 DK 98932502 T DK98932502 T DK 98932502T DK 98932502 T DK98932502 T DK 98932502T DK 0998276 T3 DK0998276 T3 DK 0998276T3
Authority
DK
Denmark
Prior art keywords
alkanoylcarnitine
derivatives
attention deficit
treat attention
hyperactive disorders
Prior art date
Application number
DK98932502T
Other languages
Danish (da)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority claimed from EP98932502A external-priority patent/EP0998276B1/en
Application granted granted Critical
Publication of DK0998276T3 publication Critical patent/DK0998276T3/en

Links

DK98932502T 1997-07-22 1998-07-08 Use of alkanoylcarnitine derivatives to treat attention deficit / hyperactive disorders DK0998276T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89843302A 1997-07-22 1997-07-22
EP98932502A EP0998276B1 (en) 1997-07-22 1998-07-08 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
PCT/IT1998/000188 WO1999004785A1 (en) 1997-07-22 1998-07-08 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders

Publications (1)

Publication Number Publication Date
DK0998276T3 true DK0998276T3 (en) 2005-06-27

Family

ID=34702422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98932502T DK0998276T3 (en) 1997-07-22 1998-07-08 Use of alkanoylcarnitine derivatives to treat attention deficit / hyperactive disorders

Country Status (1)

Country Link
DK (1) DK0998276T3 (en)

Similar Documents

Publication Publication Date Title
ATE365042T1 (en) USE OF MORPHOLINOL TO TREAT SEXUAL DISORDERS
DE69925571D1 (en) SULPHONAMIDE DERIVATIVES FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM
DE69925306D1 (en) TREATMENT OF HYDROCARBONGAS
DK2052714T3 (en) Topical gel feeding system for the treatment of skin disorders
DK1063990T3 (en) Use of Biochanine-Enriched Extract for the Treatment of Estrogen-Associated Disorders
NO20010844D0 (en) Regulation of substrate activity
DE60019556D1 (en) 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
DK0967214T3 (en) Intranasal formulations for the treatment of sexual disorders
NO20001458D0 (en) Treatment of opposition deficit disorder
ATE269303T1 (en) ARYLPIPERAZINYL-CYCLOHEXYL INDOLE DERIVATIVES FOR THE TREATMENT OF DEPRESSION
DE60019555D1 (en) 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY
NO20020062D0 (en) Treatment of neurotic disorders
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
DK1702623T3 (en) Use of interferon-gamma for the treatment of cardiac hypertrophy
DE60104791D1 (en) Cyclobutenedione derivatives for the treatment of atherosclerosis
ATE292107T1 (en) USE OF CARBONYLAMIN DERIVATIVES AGAINST CENTRAL NERVOUS SYSTEM DISORDERS
ID23175A (en) THE USE OF BENZOPIRANOL TO TREAT NERVE DISORDERS
DE60026931D1 (en) Alignment of printouts
DK1121356T3 (en) 3-tetrahydropyridin-4-yl indoles for the treatment of psychotic disorders
DK1102747T3 (en) Crystal forms of osenetant
NO20010390D0 (en) Treatment of anxiety disorders
DK0998276T3 (en) Use of alkanoylcarnitine derivatives to treat attention deficit / hyperactive disorders
DK0980241T3 (en) Gelatin-encapsulated solution dosage forms of sertraline
DE59802138D1 (en) USE OF WAX
ATE255892T1 (en) USE OF ANTICONVULSIVE DERIVATIVES TO TREAT BULIMIA NERVOSA